Hu et al. (2019) reported that formononetin at a dose of 50 mg/kg could increase the number of positive human osteosarcoma U2OS cells expressing Bcl-2 associated X protein (Bax) and apoptotic protease activating factor-1 (Apaf-1). This evidence concerns the gene APAF1 and osteosarcoma.